CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYCR), a late-stage bio-scientific research company advancing tools and testing for the early detection and diagnosis of deadly reproductive cancers, today announced that it is readying its proprietary e2 Collector™ sample retrieval device for high volume manufacturing by late summer.
